Drugs which modulate nitric oxide homeostasis are likely to provide therapeutic benefit in cardiovascular disease.
Thiemermann
C
C
William Harvey Research Institute, St Bartholomew's Hospital Medical College, London.
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D051379:Mice; D009569:Nitric Oxide / Q000037:antagonists & inhibitors* / Q000502:physiology; D051381:Rats; D012772:Shock, Septic / Q000188:drug therapy* / Q000378:metabolism; D014664:Vasodilation / Q000502:physiology; D019323:omega-N-Methylarginine
D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D001120:Arginine